Van Bergen, Tessa D.
Braat, Arthur J. A. T.
Hermsen, Rick
Heetman, Joris G.
Wever, Lieke
Lavalaye, Jules
Vinken, Maarten
Bahler, Clinton D.
Tann, Mark
Kesch, Claudia
Telli, Tugce
Chiu, Peter Ka-Fung
Wu, Kwan Kit
Zattoni, Fabio
Evangelista, Laura
Ceci, Francesco
Miszczyk, Marcin
Rajwa, Pawel
Barletta, Francesco
Gandaglia, Giorgio
Van Basten, Jean-Paul A.
Scheltema, Matthijs J.
Van Melick, Harm H. E.
Van den Bergh, Roderick C. N.
Van den Berg, Cornelis A. T.
Marra, Giancarlo
Soeterik, Timo F. W. https://orcid.org/0000-0002-0259-8750
,
Article History
Received: 26 January 2025
Accepted: 21 March 2025
First Online: 2 April 2025
Declarations
:
: This research study was conducted retrospectively from data obtained for clinical purposes. This study has been reviewed by the Medical Ethics Research United, which concluded this study does not fall under the scope of the Medical Research Involving Human Subjects Act (WMO) and does not have to be reviewed by an accredited Medical Research Ethics Committee. IRB approval was obtained and the requirement to obtain informed consent was waived due to the retrospective nature of the study (AW24.048/Z18.033).
: The requirement to obtain informed consent was waived due to the retrospective nature of the study.
: RH received consultancy fees from ABX advance biochemical compounds GmbH and Blue Earth Diagnostics.